| 1 | week | 28,551 |
| 2 | pch | 41 |
| 3 | 50x | 4 |
| 4 | mcds | 4 |
| 5 | baseline-week | 3 |
| 6 | cannes | 3 |
| 7 | 3-5/10 | 2 |
| 8 | 60.0°c | 2 |
| 9 | all.statistical | 2 |
| 10 | monostyryl-bodipy | 2 |
| 11 | post-week | 2 |
| 12 | pre-ncpap | 2 |
| 13 | rescue/symptom-free | 2 |
| 14 | sirna-hsp | 2 |
| 15 | 0.30±1.07 | 1 |
| 16 | 120-days | 1 |
| 17 | 1500000 | 1 |
| 18 | 182.1+/-81.6 | 1 |
| 19 | 19-august | 1 |
| 20 | 1at | 1 |
| 21 | 1̄ | 1 |
| 22 | 2-furylthiophenes | 1 |
| 23 | 2011.part | 1 |
| 24 | 21-october | 1 |
| 25 | 22-august | 1 |
| 26 | 24-and | 1 |
| 27 | 28-july | 1 |
| 28 | 30-february | 1 |
| 29 | 30-october | 1 |
| 30 | 52.at | 1 |
| 31 | 6-9days | 1 |
| 32 | 631.7+/-144.2 | 1 |
| 33 | 8:10 | 1 |
| 34 | acura | 1 |
| 35 | batch-scale | 1 |
| 36 | bisaldehyde | 1 |
| 37 | co-evaluate | 1 |
| 38 | consequetive | 1 |
| 39 | cps/die | 1 |
| 40 | cyanoallenes | 1 |
| 41 | cytotox | 1 |
| 42 | dtie/a | 1 |
| 43 | e3-16-g. | 1 |
| 44 | endpoint/week | 1 |
| 45 | engage-af-timi | 1 |
| 46 | g/every | 1 |
| 47 | g/laropiprant | 1 |
| 48 | gestation-day | 1 |
| 49 | gram/lrpt | 1 |
| 50 | guide-examines | 1 |
| 51 | hypertension-preeclampsia | 1 |
| 52 | h₂o₂for | 1 |
| 53 | khz/channel | 1 |
| 54 | kilogram0.75 | 1 |
| 55 | kindergarten-through-grade | 1 |
| 56 | laparosc | 1 |
| 57 | microspect | 1 |
| 58 | mmol/l/ | 1 |
| 59 | mnps-fe₃o₄for | 1 |
| 60 | mon-fri | 1 |
| 61 | more-traditional | 1 |
| 62 | nmol/gm | 1 |
| 63 | non-inductive | 1 |
| 64 | ns5a-31 | 1 |
| 65 | photocycloreversion | 1 |
| 66 | pressure-gauge | 1 |
| 67 | qlq-cx | 1 |
| 68 | rac-h | 1 |
| 69 | spray-dryer | 1 |
| 70 | tablet/night | 1 |
| 71 | v5-day | 1 |
| 72 | vandoeuvre-les-nancy | 1 |
| 73 | week+mtx | 1 |
| 74 | wieek | 1 |
| 1 | 0.30±1.07 | 1 |
| 2 | 120-days | 1 |
| 3 | 1500000 | 1 |
| 4 | 182.1+/-81.6 | 1 |
| 5 | 19-august | 1 |
| 6 | 1at | 1 |
| 7 | 1̄ | 1 |
| 8 | 2-furylthiophenes | 1 |
| 9 | 2011.part | 1 |
| 10 | 21-october | 1 |
| 11 | 22-august | 1 |
| 12 | 24-and | 1 |
| 13 | 28-july | 1 |
| 14 | 3-5/10 | 2 |
| 15 | 30-february | 1 |
| 16 | 30-october | 1 |
| 17 | 50x | 4 |
| 18 | 52.at | 1 |
| 19 | 6-9days | 1 |
| 20 | 60.0°c | 2 |
| 21 | 631.7+/-144.2 | 1 |
| 22 | 8:10 | 1 |
| 23 | acura | 1 |
| 24 | all.statistical | 2 |
| 25 | baseline-week | 3 |
| 26 | batch-scale | 1 |
| 27 | bisaldehyde | 1 |
| 28 | cannes | 3 |
| 29 | co-evaluate | 1 |
| 30 | consequetive | 1 |
| 31 | cps/die | 1 |
| 32 | cyanoallenes | 1 |
| 33 | cytotox | 1 |
| 34 | dtie/a | 1 |
| 35 | e3-16-g. | 1 |
| 36 | endpoint/week | 1 |
| 37 | engage-af-timi | 1 |
| 38 | g/every | 1 |
| 39 | g/laropiprant | 1 |
| 40 | gestation-day | 1 |
| 41 | gram/lrpt | 1 |
| 42 | guide-examines | 1 |
| 43 | hypertension-preeclampsia | 1 |
| 44 | h₂o₂for | 1 |
| 45 | khz/channel | 1 |
| 46 | kilogram0.75 | 1 |
| 47 | kindergarten-through-grade | 1 |
| 48 | laparosc | 1 |
| 49 | mcds | 4 |
| 50 | microspect | 1 |
| 51 | mmol/l/ | 1 |
| 52 | mnps-fe₃o₄for | 1 |
| 53 | mon-fri | 1 |
| 54 | monostyryl-bodipy | 2 |
| 55 | more-traditional | 1 |
| 56 | nmol/gm | 1 |
| 57 | non-inductive | 1 |
| 58 | ns5a-31 | 1 |
| 59 | pch | 41 |
| 60 | photocycloreversion | 1 |
| 61 | post-week | 2 |
| 62 | pre-ncpap | 2 |
| 63 | pressure-gauge | 1 |
| 64 | qlq-cx | 1 |
| 65 | rac-h | 1 |
| 66 | rescue/symptom-free | 2 |
| 67 | sirna-hsp | 2 |
| 68 | spray-dryer | 1 |
| 69 | tablet/night | 1 |
| 70 | v5-day | 1 |
| 71 | vandoeuvre-les-nancy | 1 |
| 72 | week | 28,551 |
| 73 | week+mtx | 1 |
| 74 | wieek | 1 |
| 1 | e3-16-g. | 1 |
| 2 | mmol/l/ | 1 |
| 3 | 1500000 | 1 |
| 4 | 3-5/10 | 2 |
| 5 | 8:10 | 1 |
| 6 | ns5a-31 | 1 |
| 7 | 631.7+/-144.2 | 1 |
| 8 | kilogram0.75 | 1 |
| 9 | 182.1+/-81.6 | 1 |
| 10 | 0.30±1.07 | 1 |
| 11 | dtie/a | 1 |
| 12 | hypertension-preeclampsia | 1 |
| 13 | acura | 1 |
| 14 | laparosc | 1 |
| 15 | 60.0°c | 2 |
| 16 | 24-and | 1 |
| 17 | kindergarten-through-grade | 1 |
| 18 | bisaldehyde | 1 |
| 19 | rescue/symptom-free | 2 |
| 20 | pressure-gauge | 1 |
| 21 | cps/die | 1 |
| 22 | batch-scale | 1 |
| 23 | co-evaluate | 1 |
| 24 | non-inductive | 1 |
| 25 | consequetive | 1 |
| 26 | rac-h | 1 |
| 27 | pch | 41 |
| 28 | engage-af-timi | 1 |
| 29 | mon-fri | 1 |
| 30 | wieek | 1 |
| 31 | week | 28,551 |
| 32 | baseline-week | 3 |
| 33 | post-week | 2 |
| 34 | endpoint/week | 1 |
| 35 | all.statistical | 2 |
| 36 | more-traditional | 1 |
| 37 | khz/channel | 1 |
| 38 | nmol/gm | 1 |
| 39 | photocycloreversion | 1 |
| 40 | pre-ncpap | 2 |
| 41 | sirna-hsp | 2 |
| 42 | 30-october | 1 |
| 43 | 21-october | 1 |
| 44 | spray-dryer | 1 |
| 45 | h₂o₂for | 1 |
| 46 | mnps-fe₃o₄for | 1 |
| 47 | mcds | 4 |
| 48 | 2-furylthiophenes | 1 |
| 49 | cyanoallenes | 1 |
| 50 | guide-examines | 1 |
| 51 | cannes | 3 |
| 52 | 120-days | 1 |
| 53 | 6-9days | 1 |
| 54 | 52.at | 1 |
| 55 | 1at | 1 |
| 56 | microspect | 1 |
| 57 | tablet/night | 1 |
| 58 | g/laropiprant | 1 |
| 59 | gram/lrpt | 1 |
| 60 | 2011.part | 1 |
| 61 | 22-august | 1 |
| 62 | 19-august | 1 |
| 63 | 50x | 4 |
| 64 | qlq-cx | 1 |
| 65 | cytotox | 1 |
| 66 | week+mtx | 1 |
| 67 | v5-day | 1 |
| 68 | gestation-day | 1 |
| 69 | vandoeuvre-les-nancy | 1 |
| 70 | 28-july | 1 |
| 71 | monostyryl-bodipy | 2 |
| 72 | 30-february | 1 |
| 73 | g/every | 1 |
| 74 | 1̄ | 1 |